Antibiotic Choices for Pediatric Periorbital Cellulitis—A 20-Year Retrospective Study from Taiwan

The delayed treatment of pediatric periorbital cellulitis may have severe consequences. In addition, the antibiotic efficacy against causative bacteria may change over time, and it is important to understand the appropriate antibiotic options for effective treatment in pediatric patients. We compare...

Full description

Bibliographic Details
Main Authors: En-Jie Shih, Jui-Kuang Chen, Pei-Jhen Tsai, Muh-Chiou Lin, Youn-Shen Bee
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/11/10/1288
_version_ 1797475903326912512
author En-Jie Shih
Jui-Kuang Chen
Pei-Jhen Tsai
Muh-Chiou Lin
Youn-Shen Bee
author_facet En-Jie Shih
Jui-Kuang Chen
Pei-Jhen Tsai
Muh-Chiou Lin
Youn-Shen Bee
author_sort En-Jie Shih
collection DOAJ
description The delayed treatment of pediatric periorbital cellulitis may have severe consequences. In addition, the antibiotic efficacy against causative bacteria may change over time, and it is important to understand the appropriate antibiotic options for effective treatment in pediatric patients. We compared the changes in cultured bacteria and drug susceptibility tests between two decades, 2010–2019 and 2000–2009, to establish antibiotics for empirical use. The patient characteristics, etiologies, culture sites, and isolated bacteria, and the antibiotic susceptibility tests of the admitted pediatric patients (<i>n</i> = 207) diagnosed with preseptal and orbital cellulitis during 2000 to 2019, were recorded. Insect/animal bites (<i>p</i> = 0.084) showed an increasing trend, and sinusitis (<i>p</i> = 0.016) showed a significant decrease in the past decades. The most common bacteria were <i>Staphylococcus aureus</i>, and methicillin-resistant <i>S. aureus</i> (MRSA) infections increased in recent decades (<i>p</i> = 0.01). Moreover, we found that vancomycin was ideal for MRSA infections. The decreasing efficacy of oxacillin correlates with the increasing proportion of MRSA in pediatric periorbital cellulitis. Our study thus offers antibiotic choices against the most common isolates that can be administered before culture results are available.
first_indexed 2024-03-09T20:50:28Z
format Article
id doaj.art-3cc8a45cbaff4d14818abe7ca504bd72
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-09T20:50:28Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-3cc8a45cbaff4d14818abe7ca504bd722023-11-23T22:33:59ZengMDPI AGAntibiotics2079-63822022-09-011110128810.3390/antibiotics11101288Antibiotic Choices for Pediatric Periorbital Cellulitis—A 20-Year Retrospective Study from TaiwanEn-Jie Shih0Jui-Kuang Chen1Pei-Jhen Tsai2Muh-Chiou Lin3Youn-Shen Bee4Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung 81362, TaiwanDivision of Infectious Diseases, Kaohsiung Veterans General Hospital, Kaohsiung 81362, TaiwanDepartment of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung 81362, TaiwanDepartment of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung 81362, TaiwanDepartment of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung 81362, TaiwanThe delayed treatment of pediatric periorbital cellulitis may have severe consequences. In addition, the antibiotic efficacy against causative bacteria may change over time, and it is important to understand the appropriate antibiotic options for effective treatment in pediatric patients. We compared the changes in cultured bacteria and drug susceptibility tests between two decades, 2010–2019 and 2000–2009, to establish antibiotics for empirical use. The patient characteristics, etiologies, culture sites, and isolated bacteria, and the antibiotic susceptibility tests of the admitted pediatric patients (<i>n</i> = 207) diagnosed with preseptal and orbital cellulitis during 2000 to 2019, were recorded. Insect/animal bites (<i>p</i> = 0.084) showed an increasing trend, and sinusitis (<i>p</i> = 0.016) showed a significant decrease in the past decades. The most common bacteria were <i>Staphylococcus aureus</i>, and methicillin-resistant <i>S. aureus</i> (MRSA) infections increased in recent decades (<i>p</i> = 0.01). Moreover, we found that vancomycin was ideal for MRSA infections. The decreasing efficacy of oxacillin correlates with the increasing proportion of MRSA in pediatric periorbital cellulitis. Our study thus offers antibiotic choices against the most common isolates that can be administered before culture results are available.https://www.mdpi.com/2079-6382/11/10/1288pediatric periorbital cellulitisetiologiesbacteriadrug susceptibility testsantibiotics
spellingShingle En-Jie Shih
Jui-Kuang Chen
Pei-Jhen Tsai
Muh-Chiou Lin
Youn-Shen Bee
Antibiotic Choices for Pediatric Periorbital Cellulitis—A 20-Year Retrospective Study from Taiwan
Antibiotics
pediatric periorbital cellulitis
etiologies
bacteria
drug susceptibility tests
antibiotics
title Antibiotic Choices for Pediatric Periorbital Cellulitis—A 20-Year Retrospective Study from Taiwan
title_full Antibiotic Choices for Pediatric Periorbital Cellulitis—A 20-Year Retrospective Study from Taiwan
title_fullStr Antibiotic Choices for Pediatric Periorbital Cellulitis—A 20-Year Retrospective Study from Taiwan
title_full_unstemmed Antibiotic Choices for Pediatric Periorbital Cellulitis—A 20-Year Retrospective Study from Taiwan
title_short Antibiotic Choices for Pediatric Periorbital Cellulitis—A 20-Year Retrospective Study from Taiwan
title_sort antibiotic choices for pediatric periorbital cellulitis a 20 year retrospective study from taiwan
topic pediatric periorbital cellulitis
etiologies
bacteria
drug susceptibility tests
antibiotics
url https://www.mdpi.com/2079-6382/11/10/1288
work_keys_str_mv AT enjieshih antibioticchoicesforpediatricperiorbitalcellulitisa20yearretrospectivestudyfromtaiwan
AT juikuangchen antibioticchoicesforpediatricperiorbitalcellulitisa20yearretrospectivestudyfromtaiwan
AT peijhentsai antibioticchoicesforpediatricperiorbitalcellulitisa20yearretrospectivestudyfromtaiwan
AT muhchioulin antibioticchoicesforpediatricperiorbitalcellulitisa20yearretrospectivestudyfromtaiwan
AT younshenbee antibioticchoicesforpediatricperiorbitalcellulitisa20yearretrospectivestudyfromtaiwan